Hims & Hers Health, Inc. (HIMS) vs Neurocrine Biosciences, Inc. (NBIX)

Hims & Hers Health, Inc. and Neurocrine Biosciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Neurocrine Biosciences, Inc. is the larger, with a market value of $14.1B against $6.9B — 2.1× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Neurocrine Biosciences, Inc. trades at 19.6×. Neurocrine Biosciences, Inc. grew revenue faster over the last twelve months: 34.4% against 28.0%. Neurocrine Biosciences, Inc. has the higher net margin (20.9% vs −5.51%) and the higher return on invested capital (15.0% vs −11.4%). Across the 20 metrics below, Neurocrine Biosciences, Inc. leads on 17 and Hims & Hers Health, Inc. on 3.